Unprecedented clinical trial results for MM
Examining changes over time in CLL cell surface markers to identify cells at different stages
Individualising treatment for elderly MM patients
Should we use the word 'cure' in CLL?
Potential combination of ibrutinib with gamma delta T-cell therapy in CLL
Iris de Weerdt